Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (181-190 of 600) with videos related to

Pageof 60
Sort By:
Arthritis and Rheumatism|February 7, 2003
Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional studyMaria-Antonietta D'Agostino, Roula Said-Nahal, Cécile Hacquard-Bouder, et al.
The Journal of Rheumatology|July 17, 2012
Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapyMark C Genovese, Michael Schiff, Michael Luggen, et al.
Rheumatology (Oxford, England)|December 15, 2020
Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritisCamille Roubille, Amandine Coffy, Nathalie Rincheval, et al.
Rheumatology (Oxford, England)|July 19, 2013
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimateIsabel Castrejón, Theodore Pincus, Martin Soubrier, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohortCécile Escalas, Marie Dalichampt, Bernard Combe, et al.
Rheumatology Advances in Practice|May 1, 2023
Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE studyBruno Fautrel, Yoram Bouhnik, Philippe Dieude, et al.
International Journal of Cardiology|February 11, 2015
Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritisAnne Tournadre, Zuzana Tatar, Bruno Pereira, et al.
Plos One|January 13, 2016
Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisGloria Crepaldi, Carlo Alberto Scirè, Greta Carrara, et al.
Arthritis and Rheumatism|October 18, 2002
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritisPatrick Garnero, Xavier Ayral, Jean-Charles Rousseau, et al.
Arthritis Care & Research|March 18, 2010
Reliability of patient self-evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessmentsPeter P Cheung, Adeline Ruyssen-Witrand, Laure Gossec, et al.
Pageof 60

Showing results (181-190 of 600) with videos related to

Sort By:
Pageof 60
Arthritis and Rheumatism|February 7, 2003
Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional studyMaria-Antonietta D'Agostino, Roula Said-Nahal, Cécile Hacquard-Bouder, et al.
The Journal of Rheumatology|July 17, 2012
Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapyMark C Genovese, Michael Schiff, Michael Luggen, et al.
Rheumatology (Oxford, England)|December 15, 2020
Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritisCamille Roubille, Amandine Coffy, Nathalie Rincheval, et al.
Rheumatology (Oxford, England)|July 19, 2013
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimateIsabel Castrejón, Theodore Pincus, Martin Soubrier, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohortCécile Escalas, Marie Dalichampt, Bernard Combe, et al.
Rheumatology Advances in Practice|May 1, 2023
Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE studyBruno Fautrel, Yoram Bouhnik, Philippe Dieude, et al.
International Journal of Cardiology|February 11, 2015
Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritisAnne Tournadre, Zuzana Tatar, Bruno Pereira, et al.
Plos One|January 13, 2016
Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisGloria Crepaldi, Carlo Alberto Scirè, Greta Carrara, et al.
Arthritis and Rheumatism|October 18, 2002
Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritisPatrick Garnero, Xavier Ayral, Jean-Charles Rousseau, et al.
Arthritis Care & Research|March 18, 2010
Reliability of patient self-evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessmentsPeter P Cheung, Adeline Ruyssen-Witrand, Laure Gossec, et al.
Pageof 60